These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 1623554)

  • 1. Transient down-regulation of PKC-zeta RNA following crosslinking of membrane IgM on WEHI-231 B lymphoma cells.
    Tsutsumi A; Freire-Moar J; Ransom JT
    Cell Immunol; 1992 Jul; 142(2):303-12. PubMed ID: 1623554
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A mutant of the WEHI-231 B lymphocyte line that is resistant to phorbol esters is still sensitive to antigen receptor-mediated growth inhibition.
    Haggerty HG; Monroe JG
    Cell Immunol; 1994 Mar; 154(1):166-80. PubMed ID: 8118885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Membrane IgM cross-linking is not coupled to protein kinase C translocation in WEHI-231 B lymphoma cells.
    Sarthou P; Henry-Toulmé N; Cazenave PA
    Eur J Immunol; 1989 Jul; 19(7):1247-52. PubMed ID: 2668012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Egr-1 mRNA expression is independent of regulatory proliferative responses in the immature B cell line WEHI-231.
    Iwabuchi N; Williams DB; Nguyen HP; Hozumi N
    Mol Immunol; 1992 May; 29(5):619-24. PubMed ID: 1584230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of protein kinase C (PKC) in agonist-induced mu-opioid receptor down-regulation: II. Activation and involvement of the alpha, epsilon, and zeta isoforms of PKC.
    Kramer HK; Simon EJ
    J Neurochem; 1999 Feb; 72(2):594-604. PubMed ID: 9930731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential regulation of mRNAs encoding protein kinase C isoenzymes in activated human B cells.
    Brick-Ghannam C; Ericson ML; Schelle I; Charron D
    Hum Immunol; 1994 Nov; 41(3):216-24. PubMed ID: 7868377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of elevated levels of protein kinase C-zeta mRNA and protein with murine B-lymphocytic neoplasia.
    Goodnight J; Mischak H; Mushinski JF
    Mol Carcinog; 1994 Nov; 11(3):131-7. PubMed ID: 7945801
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased degradation of protein kinase C without diminution of mRNA level after treatment of WEHI-231 B lymphoma cells with phorbol esters.
    Mizuguchi J; Nakabayashi H; Yoshida Y; Huang KP; Uchida T; Sasaki T; Ohno S; Suzuki K
    Biochem Biophys Res Commun; 1988 Sep; 155(3):1311-7. PubMed ID: 3263124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence for clonal heterogeneity of the expression of six protein kinase C isoforms in murine B and T lymphocytes.
    Terajima J; Tsutsumi A; Freire-Moar J; Cherwinski HM; Ransom JT
    Cell Immunol; 1992 Jun; 142(1):197-206. PubMed ID: 1586956
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lymphoma models for B cell activation and tolerance. V. Anti-Ig mediated growth inhibition is reversed by phorbol myristate acetate but does not involve changes in cytosolic free calcium.
    Scott DW; Livnat D; Whitin J; Dillon SB; Snyderman R; Pennell CA
    J Mol Cell Immunol; 1987; 3(2):109-20. PubMed ID: 3509921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteasome implication in phorbol ester- and GnRH-induced selective down-regulation of PKC (alpha, epsilon, zeta) in alpha T(3)-1 and L beta T(2) gonadotrope cell lines.
    Junoy B; Maccario H; Mas JL; Enjalbert A; Drouva SV
    Endocrinology; 2002 Apr; 143(4):1386-403. PubMed ID: 11897696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Steroid- and retinoid-mediated growth arrest and apoptosis in WEHI-231 cells: role of NF-kappaB, c-Myc and CKI p27(Kip1).
    Donjerković D; Mueller CM; Scott DW
    Eur J Immunol; 2000 Apr; 30(4):1154-61. PubMed ID: 10760805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of the cell cycle at the G2/M boundary in metastatic melanoma cells by 12-O-tetradecanoyl phorbol-13-acetate (TPA) by blocking p34cdc2 kinase activity.
    Arita Y; Buffolino P; Coppock DL
    Exp Cell Res; 1998 Aug; 242(2):381-90. PubMed ID: 9683525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of protein kinase C isoform proteins in phorbol ester-stimulated Jurkat T lymphoma cells.
    Tsutsumi A; Kubo M; Fujii H; Freire-Moar J; Turck CW; Ransom JT
    J Immunol; 1993 Mar; 150(5):1746-54. PubMed ID: 8436813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protein kinase C isoforms in muscle cells and their regulation by phorbol ester and calpain.
    Hong DH; Huan J; Ou BR; Yeh JY; Saido TC; Cheeke PR; Forsberg NE
    Biochim Biophys Acta; 1995 May; 1267(1):45-54. PubMed ID: 7779868
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of phosphoinositide-derived second messengers in mediating anti-IgM-induced growth arrest of WEHI-231 B lymphoma cells.
    Page DM; DeFranco AL
    J Immunol; 1988 Jun; 140(11):3717-26. PubMed ID: 2836499
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cross-talk between protein kinase C-alpha (PKC-alpha) and -delta (PKC-delta): PKC-alpha elevates the PKC-delta protein level, altering its mRNA transcription and degradation.
    Romanova LY; Alexandrov IA; Nordan RP; Blagosklonny MV; Mushinski JF
    Biochemistry; 1998 Apr; 37(16):5558-65. PubMed ID: 9548940
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phorbol esters and dioctanoylglycerol block anti-IgM-stimulated phosphoinositide hydrolysis in the murine B cell lymphoma WEHI-231.
    Gold MR; DeFranco AL
    J Immunol; 1987 Feb; 138(3):868-76. PubMed ID: 3027166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lymphoma models for B cell activation and tolerance. III. Cell cycle dependence for negative signalling of WEHI-231 B lymphoma cells by anti-mu.
    Scott DW; Livnat D; Pennell CA; Keng P
    J Exp Med; 1986 Jul; 164(1):156-64. PubMed ID: 3487612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of protein kinase C alpha and/or epsilon enhances transcription of the human endothelial nitric oxide synthase gene.
    Li H; Oehrlein SA; Wallerath T; Ihrig-Biedert I; Wohlfart P; Ulshöfer T; Jessen T; Herget T; Förstermann U; Kleinert H
    Mol Pharmacol; 1998 Apr; 53(4):630-7. PubMed ID: 9547352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.